
Quintiles appoints Troy Norris to head up consulting group
pharmafile | August 24, 2011 | Appointment | Research and Development |Â Â appointment, research and developmentÂ
Troy Norris has joined Quintiles as vice president and managing director for the product development and commercialisation practice at its consulting group.
At Quintiles Consulting Troy will focus on portfolio strategy and management, clinical transformation, asset valuation and transactions.
Prior to joining Quintiles, Troy held senior positions in the life sciences practices of leading strategy consulting firms including McKinsey & Co., L.E.K. Consulting and Trinity Partners.
He has also previously served as vice president of corporate development for Biogen Idec, completing multiple acquisitions to diversify the company’s R&D portfolio, and served on its business and market development team.
Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

AAX Biotech announces collaboration for cardiovascular antibody therapy
Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months
TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the …






